Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
SciSparc Ltd. - Ordinary Shares
(NQ:
SPRC
)
0.3159
+0.0100 (+3.27%)
Streaming Delayed Price
Updated: 3:55 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about SciSparc Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
SciSparc Provides Updates Regarding the Non-Binding Letter of Intent to Acquire Leading Vehicle Importer Company in Israel
December 07, 2023
From
SciSparc Ltd
Via
GlobeNewswire
Why Is Clearmind Medicine (CMND) Stock Up 50% Today?
December 05, 2023
Psychedelic-medicine specialist Clearmind Medicine posted encouraging study results, leading to a significant boost in CMND stock.
Via
InvestorPlace
Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More
December 05, 2023
Defense Dept. Funds Ketamine Study For PTSD Treatment
Via
Benzinga
Weight Loss Treatment: SciSparc’s Obesity Drug Showed Positive Results in a Pre-Clinical Trial
December 01, 2023
From
SciSparc Ltd
Via
GlobeNewswire
Why SciSparc Ltd Stock Is Blasting Higher
November 24, 2023
SciSparc Ltd.
Via
Benzinga
SciSparc Adopts Limited Duration Shareholder Rights Plan
November 28, 2023
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic-Based Treatment
November 28, 2023
From
SciSparc Ltd
Via
GlobeNewswire
EXCLUSIVE: Clearmind Medicine's Psychedelic-Based Treatment Shows Encouraging Preclinical Activity In Obesity, Metabolic Disorders
November 28, 2023
Clearmind Medicine Inc (NASDAQ: CMND) has released results from its pre-clinical trial of the combination therapy.
Via
Benzinga
What's Going On With SciSparc Shares Today?
November 27, 2023
SciSparc Ltd (NASDAQ: SPRC) shares are trading lower Monday. The company announced results for MitoCareX Bio with its drug discovery platform.
Via
Benzinga
SciSparc Announces Positive Results for MitoCareX Bio with its Drug Discovery Platform
November 27, 2023
From
SciSparc Ltd
Via
GlobeNewswire
New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder
November 24, 2023
From
SciSparc Ltd
Via
GlobeNewswire
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 22, 2023
U.S. stocks showed a positive trend on Wednesday. The Dow Jones index rose by approximately 184 points, marking an increase of 0.5% to 35,273.03.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gold Moves Lower; SciSparc Shares Spike Higher
November 22, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 175 points on Wednesday. The Dow traded up 0.50% to 35,265 while the NASDAQ rose 0.66% to 14,293.93. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Urban Outfitters Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 22, 2023
Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results.
Via
Benzinga
Crude Oil Falls Sharply; Deere Posts Upbeat Earnings
November 22, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Wednesday. The Dow traded up 0.51% to 35,266.35 while the NASDAQ rose 0.59% to 14,284.26. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is PaxMedica (PXMD) Stock Up 57% Today?
November 22, 2023
PaxMedica stock is heading higher on Wednesday as a public offering for shares of PXMD closes and the company's shares see heavy trading.
Via
InvestorPlace
Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon
November 22, 2023
Over the years, Israel has grown into an international giant in the cannabis industry.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Why Is SciSparc (SPRC) Stock Up 20% Today?
November 22, 2023
SciSparc stock is rising higher on Wednesday as SPRC investors react to the company announcing plans for a merger after a strategic review.
Via
InvestorPlace
Dow Surges 150 Points; US Jobless Claims Decline Sharply
November 22, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.43% to 35,239.40 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why SciSparc Stock Is Trading Higher Wednesday
November 22, 2023
SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company signed a non-binding letter of intent to merge with a
Via
Benzinga
SciSparc Signs Non-Binding Letter of Intent to Merge with Leading Vehicle Importer Company in Israel
November 22, 2023
From
SciSparc Ltd
Via
GlobeNewswire
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
Why SciSparc Ltd Stock Is Lighting Up
November 15, 2023
SciSparc Ltd (NASDAQ: SPRC) shares are trading higher Wednesday after the company announced positive results from the Phase IIa clinical trial of its investigational compound for the
Via
Benzinga
Why Is SciSparc (SPRC) Stock Up 47% Today?
November 15, 2023
SciSparc stock is rising higher with heavy trading of SPRC shares as investors celebrate positive clinical trial results.
Via
InvestorPlace
SciSparc Celebrates Major Breakthrough: Positive Results Show its Treatment has a Remarkable Impact on Alzheimer's Agitation
November 15, 2023
From
SciSparc Ltd
Via
GlobeNewswire
FDA-Approved Synthetic THC Trials Show 21% Tic Reduction In Tourette Syndrome Patients
November 12, 2023
SciSparc Ltd. (NASDAQ: SPRC), a clinical-stage pharmaceutical company, reported a new Phase IIb trial of SCI-110, a proprietary THC-based medication for Tourette Syndrome (TS) treatment.
Via
Benzinga
SciSparc Aims to Change Tourette Syndrome Treatments; Will Start a Phase IIb Trial with its Innovative Pharma-Grade THC-Based Medication
November 10, 2023
From
SciSparc Ltd
Via
GlobeNewswire
Dow Gains 50 Points; Global Payments Posts Upbeat Earnings
October 31, 2023
U.S. stocks turned higher toward the end of trading, with the Dow Jones index gaining around 50 points on Tuesday. The Dow traded up 0.15% to 32,978.85 while the NASDAQ rose 0.20% to 12,814.52. The S&P...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why JetBlue Airways Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Crude Oil Edges Higher; Caterpillar Earnings Top Views
October 31, 2023
U.S. stocks edged lower midway through trading, with the S&P 500 trading slightly lower on Tuesday. The Dow traded down 0.11% to 32,892.75 while the NASDAQ fell 0.23% to 12,760.61. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.